12:00 AM
Mar 18, 2013
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Zymafos palifosfamide: Phase II started

Ziopharm said investigators began a single-arm, U.S. Phase II trial to evaluate 150 mg/m 2 IV palifosfamide on days 1-3 of a 21-day cycle for up to 6 cycles in 12 patients who have relapsed on initial...

Read the full 163 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >